NCT03474107 2026-01-09A Study to Evaluate Enfortumab Vedotin Versus (vs) Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301)Astellas Pharma IncPhase 3 Completed608 enrolled 22 charts 1 FDA